Trilaciclib

(Synonyms: G1T28)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Trilaciclib (G1T28) is an orally active CDK4/6 inhibitor with IC50 values of 1 nM and 4 nM for CDK4 and CDK6, respectively. . Trilaciclib can effectively inhibit tumor cell proliferation and reduce the hematological toxicity caused by chemotherapy. Trilaciclib attenuates apoptosis and myelosuppression induced by 5FU (HY-90006) chemotherapy.

For research use only. We do not sell to patients.

  • Purity: 99.42%
  • CAS No.: 1374743-00-6
  • Formula: C24H30N8O
  • Molecular Weight:446.55
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Trilaciclib

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00